Tumor metastasis: Biobehavioral mechanisms
Tumor metastasis: Biobehavioral mechanisms
批准号:
7847325
负责人:
ANIL K SOOD
金额:
$30.84万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-24 至 2012-04-30
关键词:
AffectAnoikisApoptosisAscitesBehavioralBombesinCatecholaminesCell SurvivalCell-Matrix JunctionCellsChronic stressCytoprotectionDataDown-RegulationEmployee StrikesEpinephrineExtracellular MatrixFocal Adhesion Kinase 1FundingGoalsGrowthHormonesHumanImmunityIn VitroInvadedInvestigationLeadMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of ovaryMediatingNeoplasm MetastasisNeuropeptidesNeurosecretory SystemsNorepinephrineNormal CellOncogenesOvarian CarcinomaPTEN genePathway interactionsPlayProcessPsychosocial FactorPsychosocial StressRas/RafReceptor Protein-Tyrosine KinasesRecoveryResearchResistanceRoleSignal PathwaySiteStressTP53 geneTherapeuticTimeTumor Suppressor GenesUnited States National Institutes of HealthWorkabstractingbasebeta-adrenergic receptorbiobehaviorcancer cellin vitro Assayin vivoinhibitor/antagonistmigrationmouse modelneoplastic cellneurochemistrynoveloverexpressionparent grantprotective effectpublic health relevancetumortumor growthtumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Abstract In reference to NOT-OD-09-058 (Notice Title: NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications), we submit this Competitive Revision to the parent grant entitled "Tumor metastasis: Biobehavioral mechanisms (R01CA110793)." Psychosocial stress can elicit alterations of immunological, neurochemical, and endocrinological functions. To date, most of the research dealing with stress and tumor growth has focused on suppressed immunity; however, progressive growth of cancer is influenced by many other factors including tumor cell migration and invasion. There has been little investigation of the effect of stress hormones such as norepinephrine and epinephrine on these key processes that are required for metastasis. Focal adhesion kinase (FAK) is one of the key factors involved in tumor cell migration and invasion. We have compelling preliminary data that one of the stress hormones, norepinephrine, can directly activate FAK and promote tumor growth and these effects can be blocked by using inhibitors of beta-adrenergic receptors. Furthermore, our preliminary data suggest that FAK plays a key role in ovarian cancer migration and invasion. The parent grant has determined the underlying mechanisms and pathways by which stress hormones can affect ovarian cancer migration and invasion using in vitro assays and we have experimentally identified the in vivo effects of chronic stress on ovarian cancer progression using a well-characterized mouse model of ovarian carcinoma and are examining the associations between psychosocial factors and FAK in human ovarian cancers. During this work, we have made novel observations that chronic stress and associated increases in catecholamines protect tumor cells from undergoing anoikis, but the exact mechanisms are not well known. In the present supplement, we seek to determine whether chronic stress and associated neuroendocrine dynamics could protect ovarian cancer cells from anoikis, and to identify the underlying signaling pathways. The proposed supplement will advance the goals and objectives of the parent grant by allowing us to examine in vitro mechanisms of norepinephrine mediated protective effects against anoikis and determine in vivo effects of stress on protection of tumor cells in ascites against apoptosis (in vivo reflection of anoikis avoidance by tumor cells). Findings of this study could lead to identification of a completely new mechanism by which chronic stress affects tumor cell survival and growth, and therefore may lead to new behavioral and pharmacological therapeutic approaches.
PUBLIC HEALTH RELEVANCE: Project narrative FAK is known to promote tumor cell survival and may play a significant role in avoidance of anoikis. We have previously demonstrated that catecholamines promote ovarian carcinoma growth via stimulation of angiogenic pathways. However, the mechanism by which invading tumor cells survive anoikis remains largely unknown. The proposed work here will advance the goals and objectives of the parent grant by allowing us to examine in vitro mechanisms of norepinephrine mediated protective effects against anoikis and determine in vivo effects of stress on FAK and Src and protection of cells in ascites against apoptosis (in vivo reflection of anoikis avoidance by tumor cells).
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
A biobehavioral perspective of tumor biology.
肿瘤生物学的生物行为视角。
DOI:
--
发表时间:
2005
期刊:
Discovery medicine
影响因子:
1.4
作者:
[McDonald,PaigeGreen, Antoni,MichaelH, Lutgendorf,SusanK, Cole,StevenW, Dhabhar,FirdausS, Sephton,SandraE, Stefanek,Michael, Sood,AnilK]
通讯作者:
Sood,AnilK
DOI:
10.1371/journal.pone.0042324
发表时间:
2012
期刊:
PloS one
影响因子:
3.7
作者:
[Cohen L, Cole SW, Sood AK, Prinsloo S, Kirschbaum C, Arevalo JM, Jennings NB, Scott S, Vence L, Wei Q, Kentor D, Radvanyi L, Tannir N, Jonasch E, Tamboli P, Pisters L]
通讯作者:
Pisters L
Administrative Core
-
批准号:10709228
-
项目类别:
-
资助金额:$26.06万
-
财政年份:2023
-
负责人:ANIL K SOOD
-
依托单位:
Targeting EGFL6 in Ovarian Cancer
-
批准号:10709231
-
项目类别:
-
资助金额:$30.66万
-
财政年份:2023
-
负责人:ANIL K SOOD
-
依托单位:
Harnessing the power of exosomes for non-coding RNA delivery
-
批准号:9754614
-
项目类别:
-
资助金额:$63.31万
-
财政年份:2017
-
负责人:ANIL K SOOD
-
依托单位:
Harnessing the power of exosomes for non-coding RNA delivery
-
批准号:9979631
-
项目类别:
-
资助金额:$77.55万
-
财政年份:2017
-
负责人:ANIL K SOOD
-
依托单位:
Developmental Research Program
-
批准号:10251119
-
项目类别:
-
资助金额:$7.44万
-
财政年份:2017
-
负责人:ANIL K SOOD
-
依托单位:
Harnessing the power of exosomes for non-coding RNA delivery
-
批准号:9388779
-
项目类别:
-
资助金额:$70.48万
-
财政年份:2017
-
负责人:ANIL K SOOD
-
依托单位:
Harnessing the power of exosomes for non-coding RNA delivery
-
批准号:10670211
-
项目类别:
-
资助金额:$43.61万
-
财政年份:2017
-
负责人:ANIL K SOOD
-
依托单位:
Project 3: The Role of Macrophages in Resistance to Anti-VEGF Drugs in Ovarian Cancer
-
批准号:10005297
-
项目类别:
-
资助金额:$35.91万
-
财政年份:2017
-
负责人:ANIL K SOOD
-
依托单位:
Career Enhancement Program
-
批准号:10005302
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2017
-
负责人:ANIL K SOOD
-
依托单位:
Project 3: The Role of Macrophages in Resistance to Anti-VEGF Drugs in Ovarian Cancer
-
批准号:10251116
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2017
-
负责人:ANIL K SOOD
-
依托单位:
Career Enhancement Program
-
批准号:10251120
-
项目类别:
-
资助金额:$7.44万
-
财政年份:2017
-
负责人:ANIL K SOOD
-
依托单位:
Developmental Research Program
-
批准号:10005300
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2017
-
负责人:ANIL K SOOD
-
依托单位:
Harnessing the power of exosomes for non-coding RNA delivery
-
批准号:10461095
-
项目类别:
-
资助金额:$89.5万
-
财政年份:2017
-
负责人:ANIL K SOOD
-
依托单位:
Harnessing the power of exosomes for non-coding RNA delivery
-
批准号:10215244
-
项目类别:
-
资助金额:$68.05万
-
财政年份:2017
-
负责人:ANIL K SOOD
-
依托单位:
OVARIAN CANCER PLATELETS
-
批准号:8361105
-
项目类别:
-
资助金额:$3.68万
-
财政年份:2011
-
负责人:ANIL K SOOD
-
依托单位:
Nanotechnology Platforms for Targeting Ovarian Cancer Vasculature
-
批准号:7983097
-
项目类别:
-
资助金额:$33.92万
-
财政年份:2010
-
负责人:ANIL K SOOD
-
依托单位:
OVARIAN CANCER PLATELETS
-
批准号:8168597
-
项目类别:
-
资助金额:$0.43万
-
财政年份:2010
-
负责人:ANIL K SOOD
-
依托单位:
P2 - Targeting DII4-Notch Signaling in Ovarian Cancer
-
批准号:7961936
-
项目类别:
-
资助金额:$19.94万
-
财政年份:2010
-
负责人:ANIL K SOOD
-
依托单位:
EphA2 Targeting in Uterine Carcinoma
-
批准号:7962032
-
项目类别:
-
资助金额:$18.91万
-
财政年份:2010
-
负责人:ANIL K SOOD
-
依托单位:
Cell-specific Targeting of Ovarian Cancer Vasculature
-
批准号:7729370
-
项目类别:
-
资助金额:$18.7万
-
财政年份:2008
-
负责人:ANIL K SOOD
-
依托单位:
国内基金
海外基金
登录
查看更多内容
胃肠安方抑制整合素αvβ6促进胃癌细胞Anoikis防治胃癌转移的机制研究
-
批准号:82305335
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:卢艳琳
-
依托单位:
AMPK通路调控CEMIP诱导自噬对前列腺癌细胞anoikis耐受的影响及机制
-
批准号:81772751
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2017
-
负责人:邢毅飞
-
依托单位:
Myxoma 病毒蛋白Serp-1促进肝癌细胞Anoikis的作用及机制研究
-
批准号:81372597
-
项目类别:面上项目
-
资助金额:16.0万元
-
批准年份:2013
-
负责人:陈昊
-
依托单位:
TrkB/BDNF通路对前列腺癌EMT、anoikis和血管生成的影响及分子机制
-
批准号:81272847
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:邢毅飞
-
依托单位:
E-cadherin调控卵巢癌细胞anoikis-resistance的分子机制及干预
-
批准号:81172487
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:刘联
-
依托单位:
NDRG1在肝癌细胞抵抗Anoikis中的作用及其机制研究
-
批准号:30873025
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2008
-
负责人:曹莉莉
-
依托单位:
肝癌细胞抵抗anoikis关键分子的筛选和鉴定
-
批准号:30700357
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2007
-
负责人:韩丽辉
-
依托单位:
阻遏供体鼠胰岛整合素介导的Anoikis延长移植胰岛存活率
-
批准号:30070724
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2000
-
负责人:吴育连
-
依托单位: